Asia-Pacific Pharma & Life Sciences Newsletter – December 2011

PwC's Pharma and Life Sciences specialists are pleased to present the seventh issue of the Asia-Pac Pharmaceuticals and Life Sciences newsletter.

Our section on pricing developments includes articles from throughout the region on moves by various governments to create a more affordable market for pharmaceuticals  in Asia Pacific.

In the compliance section we have  included highlights of the latest developments in standards regarding the manufacturing of medicines and actions taken to avert the potential threat of counterfeit products.

In the tax section, on top of some good news in the region in respect of new R&D credits, new deductions for intellectual property, indirect tax reform and other tax incentives, there are some foreshadowed changes to transfer pricing rules which will need to be monitored.